Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research Indan Journal of Medical Research
  Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login  
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 1452       

   Table of Contents      
CORRESPONDENCE
Year : 2012  |  Volume : 136  |  Issue : 5  |  Page : 884

Pitfalls of interpreting ciprofloxacin minimum inhibitory concentrations in Salmonella enterica serovar Typhi


Department of Microbiology, Amrita Institute of Medical Sciences, Kochi 682 041, Kerala, India

Date of Web Publication2-Jan-2013

Correspondence Address:
Sadia Khan
Department of Microbiology, Amrita Institute of Medical Sciences, Kochi 682 041, Kerala
India
Login to access the Email id

Source of Support: None, Conflict of Interest: None


PMID: 23287141

Rights and PermissionsRights and Permissions

How to cite this article:
Khan S, Kumar V A. Pitfalls of interpreting ciprofloxacin minimum inhibitory concentrations in Salmonella enterica serovar Typhi. Indian J Med Res 2012;136:884

How to cite this URL:
Khan S, Kumar V A. Pitfalls of interpreting ciprofloxacin minimum inhibitory concentrations in Salmonella enterica serovar Typhi. Indian J Med Res [serial online] 2012 [cited 2020 Nov 28];136:884. Available from: https://www.ijmr.org.in/text.asp?2012/136/5/884/105421

Sir,

We read with interest the article on emergence of fluoroquinolone resistance in  Salmonella More Details enterica serovar Typhi in Andaman and Nicobar Islands [1] . As fluoroquinolones are widely used in the empirical therapy of enteric fever, it is important to determine the minimum inhibitory concentrations (MIC) of this group of antimicrobials in an endemic area. However, there were certain points in the article that needed clarification, which we would like to highlight:

(i) CLSI 2007 guidelines have been used though the study was conducted in 2009-2010.

(ii) The Table showed that five out of six isolates had an MIC of 0.25 μg/ml. Based on CLSI guidelines till 2011 [2] , MICs of <1 μg/ml have indicated that the organism is susceptible to ciprofloxacin. The 2012 CLSI guidelines have reduced the MIC indicating ciprofloxacin susceptibility to <0.06 μg/ml, probably making most of our strains resistant to ciprofloxacin [3] .

(iii) The authors have interpreted that five isolates of S. Typhi with MICs of 0.25 and 1 μg/ml showed intermediate level resistance to ciprofloxacin and norfloxacin, respectively. As per CLSI guidelines (2011) MICs of 2 and 8 μg/ml for ciprofloxacin and norfloxacin, respectively, indicate intermediate resistance. The authors probably implied "reduced susceptibility" to ciprofloxacin based on their molecular data. Nalidixic acid resistance in salmonellae indicates reduced susceptibility to fluoroquinolones (MICs 0.125-1 μg/ml) and may be associated with clinical failure or delayed response in fluoroquinolone treated patients [4] . It should not be confused with intermediate level resistance to fluoroquinolones.

 
   References Top

1.Tamizhmani R, Bhattacharya D, Sayi DS, Bhattacharjee H, Muruganandam N, Ghosal SR, et al. Emergence of fluoroquinolone resistance in Salmonella enterica serovar Typhi in Andaman and Nicobar Islands, India. Indian J Med Res 2012; 136 : 98-101.  Back to cited text no. 1
    
2.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. M100-S21. Wayne, Pa: CLSI; 2012.  Back to cited text no. 2
    
3.Clinical and Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement. M100-S22. Wayne, Pa: CLSI; 2012.  Back to cited text no. 3
    
4.Gaind R, Paglietti B, Murgia M, Dawar R, Uzzau S, Cappuccinelli P, et al. Molecular characterization of ciprofloxacin- resistant Salmonella enterica serovar Typhi and Paratyphi A causing enteric fever in India. J Antimicrob Chemother 2006; 58 : 1139-44.  Back to cited text no. 4
[PUBMED]    




 

Top
 
 
  Search
 
    Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
    Access Statistics
    Email Alert *
    Add to My List *
* Registration required (free)  

 
  In this article
    References

 Article Access Statistics
    Viewed392    
    Printed15    
    Emailed0    
    PDF Downloaded205    
    Comments [Add]    

Recommend this journal